Abstract:Psychosis is accompanied by severe attentional deficits, and impairments in associational-memory processing and sensory information processing that are ascribed to dysfunctions in prefrontal and hippocampal function. Disruptions of glutamatergic signaling may underlie these alterations: Antagonism of the N-methyl-D-aspartate receptor (NMDAR) results in similar molecular, cellular, cognitive and behavioral changes in rodents and/or humans as those that occur in psychosis, raising the question as to whether changes in glutamatergic transmission may be intrinsic to the pathophysiology of the disease. In an animal model of psychosis that comprises treatment with the irreversible NMDAR-antagonist, MK801, we explored the cellular mechanisms that may underlie hippocampal dysfunction in psychosis. MK801-treatment resulted in a profound loss of hippocampal LTP that was evident 4 weeks after treatment. Whereas neuronal expression of the immediate early gene, Arc, was enhanced in the hippocampus by spatial learning in controls, MK801-treated animals failed to show activity-dependent increases in Arc expression. By contrast, a significant increase in basal Arc expression in the absence of learning was evident compared to controls. Paired-pulse (PP) facilitation was increased at the 40 ms interval indicating that NMDAR and/or fast GABAergic-mediated neurotransmission was disrupted. In line with this, MK801-treatment resulted in a significant decrease in GABA(A), and increase in GABA(B)-receptor-expression in PFC, along with a significant increase of GABA(B)- and NMDAR-GluN2B expression in the dentate gyrus. NMDAR-GluN1 or GluN2A subunit expression was unchanged. These data suggest that in psychosis, deficits in hippocampus-dependent memory may be caused by a loss of hippocampal LTP that arises through enhanced hippocampal neuronal excitability, altered GluN2B and GABA receptor expression and an uncoupling of the hippocampus-prefrontal cortex circuitry.

Role of NMDA Receptor-Mediated Abnormalities of GABAergic Interneurons in Psychiatric Disorders

Functional Roles of Synaptic and Extrasynaptic NMDA Receptors in Physiological and Pathological Neuronal Activities.

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

NMDA Receptors in Nervous System Diseases

Afferent Specific Role of NMDA Receptors for the Circuit Integration of Hippocampal Neurogliaform Cells

[Advances on GABAergic Interneurons in Autism Spectrum Disorders].

NMDARs Drive the Expression of Neuropsychiatric Disorder Risk Genes Within GABAergic Interneuron Subtypes in the Juvenile Brain

NMDARs Regulate the Excitatory-Inhibitory Balance Within Neural Circuits

Extrasynaptic NMDA Receptors Bidirectionally Modulate Intrinsic Excitability of Inhibitory Neurons

NMDA receptors in nervous system diseases.

The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches

Dysfunction of NMDA receptors in Alzheimer’s disease

GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology

Roles of N-Methyl-D-Aspartate Receptors (nmdars) in Epilepsy.

Altered neuronal excitability underlies impaired hippocampal function in an animal model of psychosis

NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders

Roles of NMDA Receptor NR2A and NR2B Subtypes for Long-Term Depression in the Anterior Cingulate Cortex.

Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony

The Roles of GluN3-containing N-methyl-D-aspartate Receptor in Central Nerve System.

Significance of GABAA Receptors in the Development of Some Neuropsychiatric Diseases

The Role of the GABAergic System in Diseases of the Central Nervous System